HomeBUSINESS
BUSINESS

Seebri Neohaler Now Available in the US: Sunovion
(Oct.23.2017)

Sunovion Pharmaceuticals, a US subsidiary of Sumitomo Dainippon Pharma, said on October 19 that its long-acting muscarinic antagonist (LAMA) Seebri Neohaler Inhalation Powder (glycopyrrolate) is now available in the US ...
(LOG IN FOR FULL STORY)

News Calendar